Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Changes in Shareholders' Equity

v3.21.1
Condensed Statement of Changes in Shareholders' Equity - 3 months ended Mar. 31, 2021 - USD ($)
Total
Additional Paid-in Capital
Retained Earnings
Class A Ordinary Shares [Member]
Common Stock
Class B Ordinary Shares [Member]
Common Stock
Beginning Balance at Jan. 07, 2021 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning Balance (Shares) at Jan. 07, 2021       0 0
Issuance of Class B ordinary shares to Sponsor [1] 25,000 24,310     $ 690
Issuance of Class B ordinary shares to Sponsor (Shares) [1]         6,900,000
Sale of units in initial public offering, less fair value of warrant liabilities for public warrants 270,380,000 270,377,250   $ 2,750  
Sale of units in initial public offering, less fair value of warrant liabilities for public warrants (Shares)       27,500,000  
Offering costs (15,504,954) (15,504,954)      
Excess cash received over the fair value of the private warrants 3,466,667 3,466,667      
Class A ordinary shares subject to possible redemption (254,364,800) (254,362,256)   $ (2,544)  
Class A ordinary shares subject to possible redemption (Shares)       (25,436,480)  
Net income 998,092   998,092    
Ending Balance at Mar. 31, 2021 $ 5,000,005 $ 4,001,017 $ 998,092 $ 206 $ 690
Ending Balance (Shares) at Mar. 31, 2021       2,063,520 6,900,000
[1] This number includes up to 900,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On March 2, 2021, the underwriters partially exercised the over-allotment option to purchase as additional 3,500,000 Units; thus, 25,000 Class B ordinary shares were forfeited.